Viewing Study NCT07415005


Ignite Creation Date: 2026-03-26 @ 3:20 PM
Ignite Modification Date: 2026-03-30 @ 1:09 AM
Study NCT ID: NCT07415005
Status: NOT_YET_RECRUITING
Last Update Posted: 2026-02-17
First Post: 2026-02-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Lorlatinib Plus Local Consolidation Therapy In ALK Positive Advanced Non-Small Cell Lung Cancer
Sponsor: M.D. Anderson Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module